Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

138: Developing Adoptive Cell Therapy Strategies to Leverage Myeloid Immunity Against AML

Disclosures:   S. Oda: 1; Commercial Interest i.e. Company X; Fred Hutch Cancer Center. 1; What was received? i.e. Honorarium; Patent royalties. 1; For what role? i.e. Speaker; Patent.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.